APELOA
APELOA, officially known as APELOA Pharmaceutical Co., Ltd., is a prominent player in the pharmaceutical industry, headquartered in China (CN). Founded in 2001, the company has established a strong presence in major operational regions across Asia and beyond, focusing on the development and manufacturing of high-quality generic drugs and active pharmaceutical ingredients (APIs). With a commitment to innovation, APELOA offers a diverse portfolio of products, including oncology medications and cardiovascular treatments, distinguished by their rigorous quality standards and competitive pricing. The company has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. Recognised for its dedication to research and development, APELOA continues to contribute to global healthcare solutions, solidifying its reputation as a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does APELOA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
APELOA's score of 22 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
APELOA's reported carbon emissions
In 2024, APELOA reported total carbon emissions of approximately 615,600,000 kg CO2e, which includes 10,400,000 kg CO2e from Scope 1 emissions and 605,200,000 kg CO2e from Scope 2 emissions. The company has not disclosed any Scope 3 emissions data. Despite the significant emissions figures, APELOA has not set specific reduction targets or climate pledges, nor are there any initiatives reported under the Science Based Targets initiative (SBTi). The emissions data is sourced directly from Apeloa Pharmaceutical Co., Ltd, with no cascading from a parent or related organization. As APELOA continues to operate within the pharmaceutical industry, it is essential for the company to consider future commitments to reduce its carbon footprint and align with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2024 | |
|---|---|
| Scope 1 | 10,400,000 |
| Scope 2 | 605,200,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
APELOA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
